JP3463000004
JP3463000004
TAKEDA PHARMACEUTICAL CO LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 4.505.720.000.000 | 4.581.551.000.000 | 1.7% |
| Cost of Revenue | 1.571.588.000.000 | 1.580.217.000.000 | 0.5% |
| Gross Profit | 2.934.132.000.000 | 3.001.334.000.000 | 2.2% |
| 2.469.681.000.000 | 2.534.964.000.000 | 2.6% | |
| Operating Income | 464.451.000.000 | 466.370.000.000 | 0.4% |
| Pretax Income | -142.355.000.000 | 175.084.000.000 | 181.3% |
| Net Income Common Stockholders | -152.390.000.000 | 107.928.000.000 | 241.2% |
| -- | -- | -- | |
| -- | -- | -- |